FDA To Scrutinize Pharma Ad Pricing Claims
The U.S. Food and Drug Administration on Tuesday announced plans to study how doctors and consumers interpret prescription drug advertisements that claim one product is cheaper than another, focusing more attention...To view the full article, register now.
Already a subscriber? Click here to view full article